RedHill Biopharma Ownership

Who are the major shareholders and have insiders been buying or selling?

Recent Insider Transactions

Insider Buying: Insufficient data to determine if insiders have bought more shares than they have sold in the past 3 months.

Dilution of Shares: Shareholders have been substantially diluted in the past year, with total shares outstanding growing by 709.8%.

Top 25 shareholders own 8.51% of the company

Ownership	Name	Shares	Current Value	Change %	Portfolio %
5.49%	Heights Capital Management, Inc.	1,750,000	US$736.4k	0%	0.39%
2.03%	Empery Asset Management, LP	647,824	US$272.6k	21.1%	1.09%
0.28%	Gagnon Securities, LLC	89,589	US$37.7k	86.8%	0.01%
0.27%	Jane Street Group, LLC, Asset Management Arm	86,812	US$36.5k	0%	no data
0.11%	Rhumbline Advisers Ltd Partnership	34,847	US$14.7k	1,060%	no data
0.061%	Kenneth Reed	19,513	US$8.2k	0.43%	no data
0.049%	MGO One Seven LLC	15,750	US$6.6k	0%	no data
0.041%	Shmuel Cabilly	13,003	US$5.5k	2.12%	no data
0.034%	Squarepoint OPS LLC	10,947	US$4.6k	0%	no data
0.031%	Dror Ben-Asher	9,776	US$4.1k	6.11%	no data
0.021%	Adi Frish	6,626	US$2.8k	269%	no data
0.019%	Gilead Raday	6,121	US$2.6k	379%	no data
0.014%	Reza Fathi	4,502	US$1.9k	154%	no data
0.013%	Razi Ingber	4,197	US$1.8k	0%	no data
0.013%	Guy Goldberg	4,114	US$1.7k	319%	no data
0.0096%	Eric Swenden	3,052	US$1.3k	7.31%	no data
0.009%	Rick Scruggs	2,862	US$1.2k	0%	no data
0.0033%	Geode Capital Management, LLC	1,038	US$437.2	-0.1%	no data
0.0019%	Group One Trading LP, Asset Management Arm	615	US$258.8	0%	no data
0.0018%	Morgan Stanley, Investment Banking and Brokerage Investments	576	US$242.7	43.6%	no data
0.0013%	Alla Felder	420	US$177.0	180%	no data
0.0013%	Aspire Private Capital, LLC	405	US$170.3	0%	no data
0.0012%	Ofer Tsimchi	395	US$166.3	216%	no data
0.0011%	Yorkville Asset Management Inc.	359	US$151.5	0%	no data
0.00039%	Steward Partners Investment Advisory, LLC	125	US$52.3	0%	no data